- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02154074
Dexmedetomidine Influence on the Level of Perioperative Blood Glucose and Insulin of Elderly Diabetes Patients
May 30, 2014 updated by: Second Affiliated Hospital of Xi'an Jiaotong University
Dexmedetomidine is a kind of high selectivity alpha 2 agonists adrenaline, can inhibit the activity of sympathetic nerve, alleviate pain,and improve cardiovascular stability in the operation period.
Dexmedetomidine have influence on perioperative stress response and immune function,but it is not clear.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
92
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hongtao Liu
- Phone Number: 13572225310
- Email: lannylouis@163.com
Study Locations
-
-
Shanxi
-
Xi'an, Shanxi, China
- Recruiting
- SecondXianJiaotongU
-
Contact:
- Hongtao Liu
- Phone Number: 13572225310
- Email: lannylouis@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 60 to 80 years old;
- Type 2 diabetes;
- Not use insulin treatment;
- Onging general anesthesia surgery;
- Surgery time 1-3 hours
Exclusion Criteria:
- ASA classification > class II;
- Hypertension;
- Serious central nervous system diseases (acute stroke, uncontrolled seizures, -Severe dementia);
- Unstable angina and acute myocardial infarction;
- Allergy to investigational drug;
- Hepatic and renal dysfunction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: N1 group: Isoflurane & saline
for normal patients: inhale Isoflurane + the same volume of saline during operation
|
general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg
inhale Isoflurane 1.5MAC
the same volume of saline + Isoflurane during operation
|
EXPERIMENTAL: N2 group: Isoflurane & Dexmedetomidine
for normal patients: inhale Isoflurane + intravenous pumping Dexmedetomidine during operation
|
general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg
inhale Isoflurane 1.5MAC
anesthesia induction period: intravenous pumping Dexmedetomidine 4ug/Kg/h; after 10 minutes,turn to 0.4ug/Kg/h.
|
ACTIVE_COMPARATOR: D1 group: Isoflurane & saline
for diabetes patients: inhale Isoflurane + the same volume of saline during operation
|
general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg
inhale Isoflurane 1.5MAC
the same volume of saline + Isoflurane during operation
|
EXPERIMENTAL: D2 group: Isoflurane & Dexmedetomidi
for diabetes patients: inhale Isoflurane + intravenous pumping Dexmedetomidine during operation
|
general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg
inhale Isoflurane 1.5MAC
anesthesia induction period: intravenous pumping Dexmedetomidine 4ug/Kg/h; after 10 minutes,turn to 0.4ug/Kg/h.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
blood glucose
Time Frame: from the day before surgery to 24 hours after surgery
|
measure blood glucose at 3 time points,the day before surgery,Intraoperative(1 hour after surgery begain),one day after surgery(24 hours after surgery); examine the concentration of blood glucose in serum.
|
from the day before surgery to 24 hours after surgery
|
level of blood insulin
Time Frame: from the day before surgery to 24 hours after surgery
|
measure the level of blood insulin at 3 time points,the day before surgery,Intraoperative(1 hour after surgery begain),one day after surgery(24 hours after surgery); use ELISA to examine the concentration of blood insulin in serum.
|
from the day before surgery to 24 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
vital signs
Time Frame: duration of perioperative period
|
measure the blood pressure(BP),heart rate(HR) and oxygen saturation(SpO2) in the perioperative period
|
duration of perioperative period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2014
Primary Completion (ANTICIPATED)
October 1, 2014
Study Completion (ANTICIPATED)
October 1, 2014
Study Registration Dates
First Submitted
May 28, 2014
First Submitted That Met QC Criteria
May 30, 2014
First Posted (ESTIMATE)
June 3, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
June 3, 2014
Last Update Submitted That Met QC Criteria
May 30, 2014
Last Verified
May 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, General
- Anesthetics
- Analgesics, Non-Narcotic
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Hypnotics and Sedatives
- Anesthetics, Inhalation
- Dexmedetomidine
- Isoflurane
Other Study ID Numbers
- Dexmedetomidine 20140527
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perioperative Blood Glucose and Insulin
-
University Hospital Inselspital, BerneCompletedInsulin Therapy | Perioperative Hyperglycaemia | Elective Surgery | Closed-Loop Glucose Control | Artificial PancreasSwitzerland
-
Academisch Medisch Centrum - Universiteit van Amsterdam...European Society of Anaesthesiology and Intensive CareRecruitingInsulin Resistance | Perioperative Care | Orthopedic Surgery | Intermittent Fasting | Carbohydrate Loading | Preoperative FastingNetherlands
-
University of IoanninaCompletedMetabolic Syndrome | Anesthesia | Complications | Perioperative Outcome
-
PepsiCo Global R&DCompletedBlood Glucose; Subjective Hunger, InsulinCanada
-
Midwest Center for Metabolic and Cardiovascular...Ingredion IncorporatedCompletedBlood Glucose | Insulin Sensitivity | Dietary FiberUnited States
-
NovartisCompletedHypertension | Impaired Glucose Tolerance
-
Marjukka KolehmainenCompletedHyperglycemia | Blood Glucose, Postprandial | Blood Insulin, PostprandialFinland
-
University of ManitobaCompletedInsulin | Appetite | Faba Bean | Post-prandial Blood Glucose | Satiety HormonesCanada
-
University Hospital Bispebjerg and FrederiksbergRigshospitalet, DenmarkCompletedHypoglycemia | Perioperative ComplicationDenmark
-
Texas A&M UniversityNutraboltCompletedGlucose and Insulin Response
Clinical Trials on general anesthesia induction
-
Poitiers University HospitalCompleted
-
Daegu Catholic University Medical CenterHana Pharm Co., Ltd.CompletedGeneral AnestheticsKorea, Republic of
-
Acibadem UniversityCompletedGeneral Anesthesia | Hemodynamic InstabilityTurkey
-
Umeå UniversityCompletedAnesthesia | Airway Complication of Anesthesia | Adverse EffectSweden
-
Ain Shams UniversityCompletedAwareness, Anesthesia | Inhalation; Gas | Recall PhenomenonEgypt
-
National Taiwan University HospitalUnknownMicrocirculatory Effects of Anesthesia | Inhalation and Intravenous AnesthesiaTaiwan
-
University of JordanCompletedAnesthesia | Anesthesia; Adverse EffectJordan
-
Scios, Inc.Completed
-
Uludag UniversityCompletedPostoperative Complications | Sleep Disturbance | Regional Anesthesia MorbidityTurkey
-
The First Affiliated Hospital with Nanjing Medical...Completed